Anti-PD-L1 antibody (unspecified)

· Lee's Pharmaceutical Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-PD-L1 antibody (unspecified), covering 2022-05-04 to 2022-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. [Phase 1, Phase 2]

See pricing